A collaboration between Biofabri, a non-profit organisation, and academics from South Africa are pressing ahead with clinical development of a novel tuberculosis vaccine candidate known as
Takeda’s dengue vaccine has met its target of protection against the disease in children – but there are already concerns about mixed results among different strains of the potentially dead
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
